Large-scale testing (Phase 3)Ended earlyNCT01438112
What this trial is testing
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Who this might be right for
Transitional Cell CarcinomaBladder CancerCarcinoma in Situ+1 more
CG Oncology, Inc. 22